News & Events

Sunshine Heart, Inc. (ASX: SHC), a global medical device company focused on innovative technologies for advanced heart failure, announced that on Friday, 21 May the University of Alabama Birmingham Medical Centre successfully completed an implant of the Company’s C- PulseTM heart assist system in a patient under a clinical trial approved by the US Food and Drug Administration (FDA). This patient, whose progress is as expected, is the third implanted at University of Alabama Birmingham Medical Centre and the eighth patient to be treated with the C-Pulse heart assist system in the FDA trial.